Track Nu Skin Enterprises, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Nu Skin Enterprises, Inc. NUS Open Nu Skin Enterprises, Inc. in new tab

7.41 USD
P/E
2.24
EPS
3.18
Yield
3.24%
Safety Score
92
P/B
0.43
ROE
22.00
Beta
1.04
Nu Skin Enterprises, Inc. logo

Nu Skin Enterprises, Inc.

🧾 Earnings Recap – Q3 2025

Nu Skin Enterprises reported Q3 2025 revenue of $364 million, aligning with guidance, and delivered an EPS of $0.34, reflecting robust performance amid macro challenges. The company is poised for growth with the upcoming introduction of its Prysm iO wellness platform and entry into the Indian market.

  • Revenue declined year-over-year but remained within guidance; North America faced transformation challenges while Latin America grew 53%.
  • Launch of Prysm iO, an intelligent wellness platform, scheduled for limited previews in Q4, aiming to enhance customer engagement and lifetime value.
  • Expansion into India is a strategic focus, targeting a growing middle class with a tailored product portfolio and compensation plan to boost market presence.
  • Sequential growth noted in Europe, Africa, South Korea, and Southeast Asia, signaling recovery in key international markets.
  • Nu Skin's significant investment in intelligent wellness reflective of market trends, with a potential market for nutritional supplements anticipated to surpass $700 billion by 2030.
📅
Loading chart...
Key Metrics
Earnings dateMay 14, 2026
P/E2.24
EPS3.18
Book Value16.71
Price to Book0.43
Debt/Equity38.33
% Insiders2.571%
Growth
Revenue Growth-0.17%
Earnings Growth1.04%
Estimates
Forward P/E5.44
Forward EPS1.31
Dividend
Dividend Yield3.24%
Annual dividends0.24 USD
Ex-Div. DateFeb. 27, 2026
Payout7.39%
5y avg Yield4.64%

DCF Valuation

Tweak assumptions to recompute fair value for Nu Skin Enterprises, Inc. (NUS)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Nu Skin Enterprises, Inc. Logo Nu Skin Enterprises, Inc. Analysis (NUS)

United States Consumer Staples Official Website Stock

Is Nu Skin Enterprises, Inc. a good investment? Nu Skin Enterprises, Inc. (NUS) is currently trading at 7.41 USD.

In terms of valuation, the stock trades at a P/E ratio of 2.24. This relatively low multiple may signal that Nu Skin Enterprises, Inc. is undervalued compared to historical market norms.

Earnings Schedule: Nu Skin Enterprises, Inc. is expected to release its next earnings report on May 14, 2026. The market consensus estimate for Forward EPS is 1.31.

For income investors, Nu Skin Enterprises, Inc. pays a dividend yield of 3.24%. With a payout ratio of 7%, the dividend appears sustainable.

Investor FAQ

Does Nu Skin Enterprises, Inc. pay a dividend?

Yes, it pays an annual dividend of 0.24 USD (3.24% yield).

What asset class is Nu Skin Enterprises, Inc.?

Nu Skin Enterprises, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 14, 2026. The company currently has a trailing EPS of 3.18.

Company Profile

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Exchange Ticker
NYQ (United States) NUS
FRA (Germany) NUS.F
ASX (Australia) NUS.AX
Dividend Yield

3.24% (5y avg: 4.64%)

Annual Dividends

0.24 USD

Next ex. div date

Feb. 27, 2026

Payout Ratio

7.39%

Historical Dividends
Year Total Dividends
2027 0.06 USD
2026 0.24 USD
2025 0.24 USD
2024 0.24 USD
2023 1.56 USD
2022 1.54 USD
2021 1.52 USD
2020 1.50 USD
2019 1.48 USD
2018 1.46 USD
2017 1.44 USD
2016 1.42 USD
2015 1.40 USD
2014 1.38 USD
2013 1.20 USD
2012 0.80 USD
2011 0.59 USD
2010 0.50 USD
2009 0.46 USD
2008 0.44 USD
2007 0.42 USD
2006 0.40 USD
2005 0.36 USD
2004 0.32 USD
2003 0.28 USD
2002 0.24 USD
2001 0.20 USD

Yearly aggregated dividends

Dividends

Nu Skin Enterprises, Inc.
Mar 11, 2026 Paid
Dividend
0.06 USD
Nu Skin Enterprises, Inc.
Dec 10, 2025 Paid
Dividend
0.06 USD
Nu Skin Enterprises, Inc.
Sep 10, 2025 Paid
Dividend
0.06 USD
Nu Skin Enterprises, Inc.
Jun 11, 2025 Paid
Dividend
0.06 USD

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion